This program has concluded

Return to Classroom
Loading the player...
Closed Captioning / Subtitles Available

Information


Meds & the Brain: What Every Rehab Pro Needs to Know
Copyright :


Your client walks in and everything feels… different. Yesterday they were focused and engaged; today they’re flat, fidgety, or melting down. Is it the condition? The environment? Or the medication?

You’re not writing prescriptions — but you are on the front lines of seeing how medication shapes function. And parents, teachers, and even doctors often turn to you with questions.

This session bridges the gap between psychopharmacology and real-world therapy. You’ll learn how ADHD and autism medications impact attention, regulation, participation, and daily routines — and how to recognize when changes are tied to meds versus the diagnosis itself. We’ll cover what’s in your scope (and what isn’t), red flags you can spot first, and exactly how to document and communicate what you see.

How this session will help you in practice:

  • Plain-language explanations you can share with families about what meds do, what they don’t do, and why therapy is still essential.
  • Clarity to differentiate between a therapy problem and a med-management problem — so you know when to adapt treatment and when to refer back.
  • Real-world case examples of clients whose participation, appetite, or regulation shifted dramatically with meds, and how to respond in-session.
  • Collaborative phrasing you can use in IEP meetings, care conferences, and chart notes to advocate effectively without crossing into prescribing.
  • Confidence and clinical language to answer parent concerns, partner with prescribers, and adapt sessions when medication is in play.

Walk away with the clarity, language, and strategies you need to turn one of the most confusing parts of care into a point of strength for you, your clients, and their families.

David Dadiomov, PharmD, BCPP

David Dadiomov, PharmD, BCPP, is an assistant professor of clinical pharmacy in the Titus Family Department of Clinical Pharmacy at the USC Mann School of Pharmacy and Pharmaceutical Sciences.

He holds board certification in psychiatric pharmacy and serves as the director of the PGY2 Psychiatric Pharmacy Residency Program. He has led, co-led and conducted extensive research on opioid use disorders among vulnerable populations, prevalence and distribution of high-risk prescription opioid use, therapeutic drug monitoring, treatment-resistant psychiatric conditions and more. Dr. Dadiomov practices as a clinical pharmacy specialist in addiction and psychiatry at the Complex Care Clinic of the Los Angeles County Department of Health Services, one of the largest of its kind in the United States.

Dr. Dadiomov’s teaching approach is case focused, practical for any clinical setting, interactive and evidence supported. His expertise has been shared with experienced clinicians, graduate students and advanced level students. Dr. Dadiomov is the recipient of multiple awards for clinical excellence, teaching and clinical innovation and has presented, authored and co-authored multiple peer-reviewed journal articles, book chapters, and scientific presentations.

 

Speaker Disclosures:
Financial: Dr. David Dadiomov has employment relationships with the University of Southern California Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California Psychiatry and behavioral Sciences Medical Residency, and the Los Angeles County Department of Health Services. He previously received a speaking honorarium from Eli Lilly. Dr. Dadiomov receives grants from the 2024 SC CTSI Standard Pilot Grand Program, the USC Good Neighbors Grant Program, the Southern California Clinical and Translational Sciences Institute, and the Foundation for Opioid Response Efforts. He receives a speaking honorarium and recording royalties from Psychotherapy Networker and PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. David Dadiomov is a member of the American Society of Addiction Medicine, the American Association of Psychiatric Pharmacists, the American College of Clinical Pharmacy, and the American Society of Health-System Pharmacists. He is a reviewer for several publications, for a complete list contact PESI.com.

Toolbar

PLEASE UPGRADE TO A MODERN BROWSER

FOR A BETTER EXPERIENCE. KEEP YOUR BROWSER UP TO DATE
Download Google Crome Browser Download Firefox Browser
CONTINUE FORWARD IN MY CURRENT BROWSER (Mozilla 0.0)
OK
Restart the Seminar
Restart Section